ÌÇÐÄÆƽâ°æ

Market share of Novo Nordisk's medication sales in the diabetes care market in China in December 2023, by category

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

March 2024

Region

China

Survey time period

December 2023

Special properties

excluding Hong Kong and Taiwan

Citation formats

Sales share of Novo Nordisk's drugs in Chinese diabetes market 2023, by segment

Published by A. Minhas, Sep 2, 2024

In December 2023, the Danish pharmaceutical company Novo Nordisk controlled more than half of the insulin market in China, in terms of sales volume. Founded in 1923, the firm specializes in producing diabetes medications, which accounted for around ** percent of its annual sales revenue in 2023.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Diabetes in China "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Diabetes in China

Demographics

5

Medications

6

Blood glucose monitoring equipment

8

Outlook

4

Further Content: You might find this interesting as well

Topics

Diabetes in ChinaOverweight and obesity in the United StatesDiabetesVaccine industry in ChinaAging population in China
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.